MSB 7.69% $1.19 mesoblast limited

Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial, page-73

  1. 15,454 Posts.
    lightbulb Created with Sketch. 5535
    I see it as a positive ...

    1. We get more data from the continuation to support an approval;

    2. It is working and saving lives or it would have been stopped for futility.

    Amazing how some of the naysayers are spinning it - who would have thought people could be negative about a medical treatment that is obviously working and saving lives in a once in a hundred year pandemic - go figure !
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.